COVID-19 Important Information

COVID-19 Update

The Federal and Massachusetts COVID-19 Public Health Emergency Declarations ended on May 11, 2023.
Here’s what has changed—and what will stay the same. 
Free COVID-19 vaccinations continue:
  •  COVID-19 vaccines continue to be free to everyone in Massachusetts.
Free COVID-19 treatments continue:
  • Free telehealth services for COVID-19 treatment continues to be available to Massachusetts residents ages 18 and older. This is a quick and easy way for people who have COVID-19 to see if Paxlovid is right for them. If it is, the medicine is free and can be picked up at a local pharmacy or shipped overnight with free delivery. Learn more at mass.gov/CovidTelehealth
COVID-19 vaccine dose guidance has changed:
  • The CDC issued guidance in April saying that people ages 6 and older are considered up to date on their COVID-19 vaccination if they have one dose of the bivalent vaccine.
  • People who have never had a COVID-19 vaccination are up to date if they get one dose of the bivalent vaccine.
  • People ages 65 and older or who are immunocompromised can get an additional bivalent dose. Learn more at mass.gov/COVIDvaccine
The way we talk about COVID vaccine doses has changed:
  • Instead of using terms like “boosters” and “primary series,” we are shifting toward talking about doses—and specifically, bivalent doses.
  • If people don’t know if they had a bivalent dose, there are ways to find out. 
    • Children ages 6 and over who got a booster on October 12, 2022 and children 12 and over and adults who got their last booster on or after September 2, 2022 would have received a bivalent dose.
  • Vaccination cards say if someone had a bivalent dose. People can also look up their online vaccination records or contact the place they got their last dose. 
COVID-19 vaccination clinics continue:
  •  DPH Mobile and the Vaccine Access and Administration (VAA) program will continue to provide clinics upon request from community partners through the Clinic Request Form.
  • DPH’s In-home vaccination program will continue to provide services. Information and a link to request in-home vaccinations are on www.mass.gov
Federal and State mask mandates are ending:
  • • Federal and State mask mandates, including for hospitals, ended on May 11, but healthcare settings must have their own infection control policies that include masking when there is respiratory illness in their community.
Yearly renewal for MassHealth is starting up again:
  • •MassHealth members should make sure their information with MassHealth is updated.  They may need to provide new documentation so that they can stay in the program.  Visit www.mass.gov/masshealth for more information.  
Free home COVID-19 test availability will change:
  • After May 11, the federal government will no longer supply individuals with free at-home tests for COVID-19, but many organizations can order them at a discount. Visit the statewide contract ordering information page for COVID tests to learn more. Insurers are no longer required to cover monthly at-home tests.
  • MassHealth and other insurance will continue to cover COVID-19 PCR testing when ordered by a healthcare provider.

COVID-19 Information - Regularly Updated

  • City of Taunton COVID-19 Information Line: 774-406-5277
  • The Board of Health will no longer be posting reports on a weekly basis, but will continue to monitor COVID-19 cases among Taunton residents.  
  • Any questions may be directed to the Board of Health at 508-821-1400 or the COVID Information Line at 774-406-5277.

New COVID-19 Treatment Hotline

  • Tested positive for COVID-19? Telehealth is a quick and free way to see if you’re eligible for COVID-19 treatment.
  • You can access telehealth services by calling 833-273-6330 or by completing an online assessment at mass.gov/CovidTelehealth
  • Clinicians are available every day from 8:00 AM to 10:00 PM EST
  • This service is not for medical emergencies or those who have severe chest pain or shortness of breath.     

Vaccine Information


COVID-19 Vaccine Update

As of April 18, 2023, the monovalent Moderna and Pfizer COVID-19 vaccines are no longer authorized for use in the U.S.

Following FDA regulatory action on April 18th, CDC has taken steps to simplify COVID-19 vaccine recommendations and allow more flexibility for people at higher risk who want the option of added protection from an additional COVID-19 vaccine dose. 

CDC’s Advisory Committee on Immunization Practices (ACIP) met April 19th to discuss these COVID-19 vaccine recommendation changes, and the associated implications and implementation. Although there was no vote at this meeting, ACIP members expressed their support for these recommendations.

These changes include:

Monovalent (original) COVID-19 mRNA COVID-19 vaccines will no longer be used in the United States.

CDC recommends that everyone ages 6 years and older be up to date with their vaccines, which includes receiving a bivalent booster dose.

For those who have not yet received a monovalent primary series, CDC now recommends a single bivalent dose.

Individuals ages 6 years and older who have already received an updated mRNA vaccine do not need to take any action unless they are 65 years or older or immunocompromised.

For young children (6 months through 5 years), multiple doses continue to be recommended and will vary by age, vaccine, and which vaccines were previously received.

CDC’s new recommendations allow an additional updated (bivalent) vaccine dose for adults ages 65 years and older and additional doses for people who are immunocompromised. This allows more flexibility for healthcare providers to administer additional doses to immunocompromised patients as needed.

Alternatives to mRNA COVID-19 vaccines remain available for people who cannot or will not receive an mRNA vaccine. CDC’s recommendations for use of (monovalent) Novavax or Johnson & Johnson’s Janssen COVID-19 vaccines were not affected by recent changes.

CDC and ACIP will continue to monitor COVID-19 disease levels and vaccine effectiveness in the months ahead and will plan on additional discussion around potential updates this fall.

What are the differences between monovalent and bivalent vaccines?

A monovalent vaccine is a vaccine with one strain of a virus. A bivalent vaccine is a vaccine with two strains of a virus. Many different vaccines have both monovalent and bivalent versions, including flu vaccines and COVID- 19 vaccines.

City of Taunton COVID-19 Vaccine Availability Information

Currently being vaccinated: all MA residents ages 6 months and older are eligible for the vaccine

  1. CVS Pharmacy
  2. Hannaford (Taunton)
  3. Walgreens 
  4. Walmart 
  5. Manet Community Health Center (Taunton)

Use VaxFinder to search for appointments at additional pharmacies, health care providers, and other community locations.

COVID-19 Testing in Taunton / Raynham

  1. CVS COVID-19 Testing - Taunton: Washington Street, Winthrop Street/Raynham: Broadway
  2. Walgreens COVID-19 Testing - Taunton: Broadway, Winthrop Street, Dean Street
  3. Raynham Taunton Pediatrics COVID-19 Testing (Patients Only) - 876 Broadway, Raynham
  4. Health Express Raynham COVID-19 Testing - 106 New State Highway, Raynham
  5. Free COVID-19 (PCR) testing is provided at Bristol Community College in Fall River. This is a drive-through service and test results are generally available within 24 to 48 hours. To book an appointment, please visit the 10 to 8 website

For additional locations, please refer the Department of Health: Find Covid-19 Test website.

At home COVID-19 testing is available at no cost to all eligible Massachusetts adults.

Kits are reserved for adults (18+) who live or work in a congregate setting, are experiencing symptoms, have recently been in contact with someone with COVID-19, or who have otherwise been recommended for testing.

Please visit the Pixel by LabCorp for Massachusetts website for details, and to request a test kit.

For all eligible individuals, this COVID-19 test is provided at no cost to you and is covered by your health insurance plan or, if you do not have health insurance, by the federal government. To be eligible to receive this test, at no cost to you, you must meet one or more of the criteria. If you do not meet any of the eligibility criteria, you may still be eligible to receive testing at no cost to you at one of the testing sites in Massachusetts.

FDA Novavax

FDA Authorizes Emergency Use of Novavax COVID-19 Vaccine

On July 13, 2022, the Centers for Disease Control (CDC) endorsed an advisory committee's recommendation that the Novavax COVID-19 vaccine be used as a primary series option for adults.

"We have expanded the options available to adults in the U.S. by recommending another safe and effective COVID-19 vaccine. If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated," CDC Director Dr. Rochelle Walensky said in a statement. "With COVID-19 cases on the rise again across parts of the country, vaccination is critical to help protect against the complications of severe COVID-19 disease."

For more information, please visit the FDA U.S. Food and Drug Coronavirus (Covid-19) Update website.